Steven Liakos
Gastroenterology · Marlton, NJNPI 1295713212
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,256 and has fallen 90.4% since, to $120 in 2024.
Across 185 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$692
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$403
- Johnson & Johnson$358
- Takeda Pharmaceuticals U.S.A., Inc.$294
- Gilead$268
- Janssen Scientific Affairs, LLC$227
- plus $869 from 14 others
Across 14 payments — averaging $11,554 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$161K
- UCB Biosciences Inc.$1K
What the payments were for
- Consulting fees$130%
- Food & beverage$2,99996%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $692 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 41 | $403 |
| Johnson & Johnson | 23 | $358 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $294 |
| Gilead | 17 | $268 |
| Janssen Scientific Affairs, LLC | 2 | $227 |
| Pfizer | 7 | $178 |
| QOL Medical, LLC | 11 | $151 |
| Amgen | 1 | $120 |
| Evoke Pharma, Inc. | 1 | $117 |
| Braintree Laboratories, Inc. | 5 | $73 |
| Ironwood Pharmaceuticals, Inc | 4 | $57 |
| Bristol Myers Squibb | 3 | $41 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Merck | 2 | $27 |
| UCB, Inc. | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $13 |
| ERBE USA Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,111 in reported general payments places this provider in the 55th percentile of 701 gastroenterology providers in New Jersey.
Other gastroenterology in Marlton
- Vinod RustgiNew Brunswick$431K
- Zamir BrelviNewark$391K
- Adam ElfantMount Laurel$385K
- Devjit NayarHoboken$258K
- Lea ChenNew Brunswick$185K
- Alexander PerelmanWest Orange$160K
- Barry KaufmanEgg Harbor Township$157K
- Anish ShethPrinceton$151K
- Ramesh GuptaFair Lawn$143K
- Sanket PatelVoorhees$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.